News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Conference News ACC 2019 PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital Michael O'Riordan March 25, 2019
News Conference News ACC 2019 Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE Caitlin E. Cox March 25, 2019
News Daily News FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure Yael L. Maxwell March 22, 2019
News Conference News ACC 2019 CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year Yael L. Maxwell March 20, 2019
News Opinion Editor's Corner ACC 2019 Live From New Orleans: Days 2 and 3 at ACC 2019 Shelley Wood March 18, 2019
News Conference News ACC 2019 COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions Shelley Wood March 17, 2019
News Daily News HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR L.A. McKeown March 13, 2019
News Daily News How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting Shelley Wood February 26, 2019
News Industry News Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure February 25, 2019
News Daily News ‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests L.A. McKeown January 17, 2019
News Daily News None of the Usual Suspects? Troponin Elevation Still Warrants Attention Shelley Wood January 11, 2019
News Daily News Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction Todd Neale January 09, 2019
News Daily News MitraClip Analysis Highlights Questions of Patient Selection in Functional MR Shelley Wood January 04, 2019
Manuscript Determinants and Prognostic Value of Longitudinal Strain in Asymptomatic Aortic Stenosis and Preserved Left Ventricular Ejection Fraction—The COFRASA/GENERAC Study July 27, 0207
Video » Interview ACC 2019: PANACHE: Safety and Efficacy of Neladenoson Bialanate, a Partial Adenosine A1 Receptor Agonist, in Patients with Heart Failure and Preserved Ejection Fraction: Results from the PANACHE Randomized Controlled Trial March 18, 2019